Completed PHASE3 INTERVENTIONAL 2-arm NCT02433925

Resveratrol's Effects on Inflammation and Oxidative Stress in Chronic Kidney Disease

Effects of Supplementation With Resveratrol on Inflammation and Oxidative Stress of Non-dialysis Chronic Kidney Disease Patients

Sponsor: Universidade Federal Fluminense

Conditions Chronic Renal Insufficiency

Interventions Placebo Resveratrol

Updated 6 times since 2017 Last updated: Apr 29, 2015 Started: Jan 31, 2013 Primary completion: Jan 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Chronic Renal Insufficiency, this trial is completed. The trial is conducted by Universidade Federal Fluminense and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidade Federal Fluminense

Data source: Universidade Federal Fluminense

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.